par 544 (Ranitidine 150 mg)
Pill imprint par 544 has been identified as Ranitidine hydrochloride 150 mg.
Ranitidine is used in the treatment of gerd; erosive esophagitis; stomach ulcer; gastric ulcer maintenance treatment; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for par 544 (Ranitidine 150 mg)
- 150 mg
- 9.00 mm
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- FD&C Yellow No. 6
pregelatinized corn starch
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|62584-0252||Amerisource Health Services|
|63739-0266||McKesson Packaging Services|
|66267-0188||Nucare Pharmaceuticals Inc (repackager)|
|67544-0146||Prepak Systems Inc (repackager)|
|21695-0109||Rebel Distributors Corp (repackager)|
|68258-1072||Dispensing Solutions Inc. (repackager)|
|68115-0787||Dispensexpress Inc (repackager)|
|49999-0043||Lake Erie Medical and Surgical Supply (repackager)|
|68115-0314||Dispensexpress Inc (repackager)|
|18837-0133||Innoviant Pharmacy Inc (repackager)|
Note: Inactive ingredients may vary.